SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea
· Delayed Price · Currency is KRW 1,364.00
+20.00 (1.49%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Prescription Drugs | 37.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Prescription Drugs Growth | -14.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| General Drugs and Over-the-counter Drugs | 4.11B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| General Drugs and Over-the-counter Drugs Growth | -31.70% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Functional Foods | 1.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Health Functional Foods Growth | -8.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 1.38B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 73.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals and Quasi-drugs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals and Quasi-drugs Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| South Korea | 44.29B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -14.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Overseas Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|